Clarus Therapeutics Holdings Incis A Pharmaceutical Company Based In Northbrookillinoisfocused On Developing And Marketing Oral Drugs For Testosterone Deficiency And Hypogonadismfounded In 2003 By Drrobert Edudleythe Company Initially Addressed Men S Health Issues Such As Benign Prostatic Hyperplasia And Erectile Dysfunctionover The Yearsit Has Expanded Its Offerings And Now Provides More Than 20 Products Across Various Therapeutic Areas One Of Its Key Products Is Jatenzoa Proprietary Softgel Capsule That Contains A Testosterone Prodrug And Testosterone Undecanoatethis Formulation Allows For Absorption Through The Intestinal Lymphatic Systemminimizing The Risk Of Testosterone Transfer To Women And Childrenclarus Therapeutics Also Develops Testosterone Replacement Therapies And Collaborates With Other Pharmaceutical Companies To Enhance Its Product Portfolio And Reach Within The Industry
